Results 151 to 160 of about 365,054 (191)

<i>Chlamydia trachomatis</i>: a model for intracellular bacterial parasitism. [PDF]

J Bacteriol
Smith EP, Valdivia RH.
europepmc   +1 more source

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study. [PDF]

Clin Infect Dis
Landovitz RJ, Pinedo Y, Hinestrosa F, Crofoot GE, Brinson C, Buchbinder S, Molina JM, Gravett RM, Brock JB, Ramgopal MN, Lina Rosengren A, Ofotokun I, Valdez Madruga J, Liegeon G, Panchia R, Supparatpinyo K, Avihingsanon A, Creticos C, Swaminathan S, Doblecki-Lewis S, Rodriguez J, Siegel M, Oka S, Puthanakit T, Grinsztejn B, Sanders EJ, Lama JR, Lombaard J, Ndlovu N, Hwang P, Du J, Jackson B, Homony B, Evans B, Sklar P, Robertson MN, Plank RM.   +36 more
europepmc   +1 more source

Persistence of Chlamydial Antibodies After Pelvic Inflammatory Disease. [PDF]

Journal of Clinical Microbiology, 1986
The persistence of chlamydial immunoglobulin G (IgG) antibodies and long-term sequelae of pelvic inflammatory disease (PID) were studied in 70 women who had been treated for PID 3 to 6 years previously. Fifty-one women had had PID associated with Chlamydia trachomatis infection (Chlamydia group), and 19 women had had PID not associated with C ...
Mirja Puolakkainen, J Paavonen, E Vesterinen   +2 more
exaly   +3 more sources

Chlamydial Clinical Isolates Show Subtle Differences in Persistence Phenotypes and Growth in Vitro

Access Microbiology, 2021
Urogenital Chlamydia trachomatis infection is the most common sexually transmitted bacterial infection throughout the world. While progress has been made to better understand how type strains develop and respond to environmental stress in vitro, very few studies ...
Jane S. Hocking, Wilhelmina M. Huston, Peter Timms   +2 more
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Role of Tryptophan in Gamma Interferon-Mediated Chlamydial Persistence

Annals of the New York Academy of Sciences, 1994
Richard P Morrison, G I Byrne
exaly   +3 more sources

Persistence of Chlamydial Infection After Treatment for Neonatal Conjunctivitis. [PDF]

Archives of Disease in Childhood, 1981
A high incidence of pharyngeal infection was found in babies with isolation-positive chlamydial conjunctivitis. Chlamydia trachomatis was isolated from the pharynx of 12 (52%) of 23 babies before treatment, and was reisolated from the eyes of 4 (12%) of 34 and from the pharynx of 14 (41%) of 34 after treatment.
I A Tait, E Rees, D Hobson
exaly   +3 more sources

Transcriptome Analysis of Chlamydial Growth During IFN-γ-Mediated Persistence and Reactivation [PDF]

Proceedings of the National Academy of Sciences of the United States of America, 2003
Chlamydia trachomatis is an obligatory intracellular prokaryotic parasite that causes a spectrum of clinically important chronic inflammatory diseases of humans. Persistent infection may play a role in the pathophysiology of chlamydial disease. Here we describe the chlamydial transcriptome in an
Harlan D Caldwell, Deborah D Crane
exaly   +3 more sources

Persistent Urethral Leukocytosis and Asymptomatic Chlamydial Urethritis

Journal of Infectious Diseases, 1979
Chlamydia trachomatis was isolated from 47% of asymptomatic, sexually active men whose urethral smears contained four or more polymorphonuclear leukocytes (PMN) per high-power field (hpf) one week after their sexual activity was restricted. C. trachomatis was not detected in any of 23 asymptomatic, sexually active men having less than 4 PMN/hpf in two ...
S L, Swartz, S J, Kraus
openaire   +2 more sources

Persistence, Relapses, and Reinfections of Chlamydial Infections

1989
Chlamydial infections can remain clinically silent for a considerable period of time. Both human beings and animals can be carriers of C. trachomatis and C. psittaci for years.
Jorma Paavonen, Pers-Anders Mårdh
exaly   +2 more sources